Ramon Andrade Bezerra De Mello (Ramon Andrade de Mello, Ramon Andrade De Mello, Ramon Andrade Bezerra de Mello, Ramon Andrade De Mello)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Immunotherapy

Journal of clinical medicine

Cancers

Future oncology (London, England)

Hospital Israelita Albert Einstein

Universidade do Porto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Israelita Albert Einstein

Brazil

Medical Oncologist :: Medicine - Bloco A1 Einstein Clinics

Universidade Federal de Sao Paulo Escola Paulista de Medicina

Brazil

Professor of Medical Oncology :: Department of Clinical and Experimental Oncology

Universidade do Algarve

Portugal

Professor of Medicine and Oncology :: Departamento de Ciências Biomédicas e Medicina

Bauru State Hospital

Brazil

Consultant in Medical Oncology :: Oncology & Hematology

Clatterbridge Cancer Centre NHS Foundation Trust

United Kingdom

Locum Consultant in Medical Oncology :: Chemotherapy

Western General Hospital

United Kingdom

Locum Consultant Medical Oncology :: Oncology

Instituto Português Oncologia

Portugal

IFE Oncologia Médica :: Oncologia Médica

Hospital São João

Portugal

IFE Medicina Interna :: Medicina Interna

Unidade Local de Saúde Norte Alentejano, Portalegre

Portugal

Interno do ano comum

Education History

Universidade do Porto

Portugal

PHD :: Faculty of Medicine

Publications

Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Puteri Abdul Haris
What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers? Immunotherapy (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy (2024)
Kátia Roque Perez, Rossana Ruiz, Luis Mas, Daniel Humberto Pozza, Marina Vancini, José Antônio Silva Júnior, Ramon Andrade Bezerra De Mello
Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices. Cancers 15 (18) (2023)
Kátia Roque Perez, Rossana Ruiz, Iris Otoya-Fernandez, José Galarreta, Tatiana Vidaurre, Ramon Andrade Bezerra De Mello, Silvia P Neciosup, Luis Mas, Henry L Gómez
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic. Future oncology (London, England) (2022)
Ramon Andrade Bezerra De Mello, Giovanna Araújo Amaral, Carla Chizuru Tajima, Hakaru Tadokoro, Jairo Iavelberg, Débora Simonetti, Maria Tolia, José Antonio Silva
Potential role of immunotherapy for advanced breast cancer. Immunotherapy 13 (8) (2021)
Guangsheng Zhu, Dian Ren, Xi Lei, Ruifeng Shi, Shuai Zhu, Ning Zhou, Lingling Zu, Ramon Andrade Bezerra De Mello, Jun Chen, Song Xu
Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer. Cancers 13 (6) (2021)
Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, Aryeh J Price, Ramon Andrade Bezerra De Mello, Ana D Marreiros, Ricardo Pires das Neves, Pedro Castelo-Branco
Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers? Current oncology (Toronto, Ont.) 28 (6) (2021)
Ramon Andrade Bezerra De Mello, Giovanna Araújo Amaral, Nathália Moisés Neves, Estela Gudin Lippo, Fernanda Parini, Song Xu, Maria Tolia, Nikolaos Charalampakis, Hakaru Tadokoro, Pedro Castelo-Branco, Jinhui Zhu
Current and potential biomarkers in gastric cancer: a critical review of the literature. Future oncology (London, England) 17 (25) (2021)
Ramon Andrade Bezerra De Mello, Rafael Voscaboinik, João Vittor Pires Luciano, Rafaela Vilela Cremonese, Giovanna Araujo Amaral, Pedro Castelo-Branco, Georgios Antoniou
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives. Cancers 14 (1) (2021)
Ramon Andrade Bezerra De Mello, Giovanna Araújo Amaral
Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside. Journal of clinical medicine 9 (10) (2020)
Ramon Andrade Bezerra De Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo-Branco, Victor André de Almeida Zia
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives. Journal of clinical medicine 9 (11) (2020)
Ramon Andrade Bezerra De Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo-Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Georgios Antoniou
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer. Journal of clinical medicine 9 (6) (2020)

Ramon Andrade Bezerra De Mello.css-eqlu8i{font-size:small;padding-left:4px;} (Ramon Andrade de Mello, Ramon Andrade De Mello, Ramon Andrade Bezerra de Mello, Ramon Andrade De Mello)

Publication Activity (10 Years)

Top Topics

Top Venues

Ramon Andrade Bezerra De Mello (Ramon Andrade de Mello, Ramon Andrade De Mello, Ramon Andrade Bezerra de Mello, Ramon Andrade De Mello)